KYTX
Kyverna Therapeutics, Inc. SEC filings
Every EDGAR filing for Kyverna Therapeutics, Inc. (KYTX), newest first, with AI summaries and stories.
- Ticker
- KYTX
- CIK
- 1994702
- Sector
- Biotech and pharma
- Latest filing
- Sep 24
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Filings
8-KKyverna Therapeutics, Inc.KYTXLIVE SCHEDULE 13G/AKyverna Therapeutics, Inc.KYTXLIVE Ownership stake disclosure by Bain Capital Life Sciences Opportunities III, LP (amended)
Bain Capital Life Sciences Opportunities III, LP, filed by
10-QKyverna Therapeutics, Inc.KYTXLIVE 8-KKyverna Therapeutics, Inc.KYTXLIVE SCHEDULE 13GKyverna Therapeutics, Inc.KYTXLIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
8-KKyverna Therapeutics, Inc.KYTXLIVE 8-KKyverna Therapeutics, Inc.KYTXLIVE 8-KKyverna Therapeutics, Inc.KYTXLIVE 4Kyverna Therapeutics, Inc.KYTXLIVE 5 insider filings
Beth C Seidenberg, insider filing for KYTX
Show all 5
- 4Insider filing for KYTX
- 4Insider filing for KYTX
- 4Insider filing for KYTX
- 4Insider filing for KYTX
- 4Insider filing for KYTX
Beth C Seidenberg, reporting
3Kyverna Therapeutics, Inc.KYTXLIVE 2 insider filings
Gregory S. Martini, new insider at KYTX
Show all 2
- 3New insider at KYTX
- 4Insider filing for KYTX
Gregory S. Martini, reporting
8-KKyverna Therapeutics, Inc.KYTXLIVE 8-KKyverna Therapeutics, Inc.KYTXLIVE 10-QKyverna Therapeutics, Inc.KYTXLIVE 3Kyverna Therapeutics, Inc.KYTXLIVE 2 insider filings
Nadia Dac, new insider at KYTX
Show all 2
- 3New insider at KYTX
- 4Insider filing for KYTX
Nadia Dac, reporting
8-KKyverna Therapeutics, Inc.KYTXLIVE 8-KKyverna Therapeutics, Inc.KYTXLIVE 8-KKyverna Therapeutics, Inc.KYTXLIVE 144Kyverna Therapeutics, Inc.KYTXLIVE Karen Marie Walker, planned sale of KYTX shares
Karen Marie Walker, reporting
144Kyverna Therapeutics, Inc.KYTXLIVE Karen Marie Walker, planned sale of KYTX shares
Karen Marie Walker, reporting
ARSKyverna Therapeutics, Inc.KYTXLIVE DEFA14AKyverna Therapeutics, Inc.KYTXLIVE DEF 14AKyverna Therapeutics, Inc.KYTXLIVE 144Kyverna Therapeutics, Inc.KYTXLIVE Daniel K Spiegelman, planned sale of KYTX shares
Daniel K Spiegelman, reporting
EFFECTKyverna Therapeutics, Inc.KYTXLIVE 424B5Kyverna Therapeutics, Inc.KYTXLIVE 144Kyverna Therapeutics, Inc.KYTXLIVE Daniel K Spiegelman, planned sale of KYTX shares
Daniel K Spiegelman, reporting
S-8Kyverna Therapeutics, Inc.KYTXLIVE S-3Kyverna Therapeutics, Inc.KYTXLIVE 10-KKyverna Therapeutics, Inc.KYTXLIVE 8-KKyverna Therapeutics, Inc.KYTXLIVE 4Kyverna Therapeutics, Inc.KYTXLIVE 3 insider filings
Marc Grasso, insider filing for KYTX
Show all 3
- 4Insider filing for KYTX
- 4Insider filing for KYTX
- 4Insider filing for KYTX
Marc Grasso, reporting
3Kyverna Therapeutics, Inc.KYTXLIVE 2 insider filings
Andrew Craig Miller, new insider at KYTX
Show all 2
- 3New insider at KYTX
- 4Insider filing for KYTX
Andrew Craig Miller, reporting
4Kyverna Therapeutics, Inc.KYTXLIVE 2 insider filings
Sravan Kumar Emany, insider filing for KYTX
Show all 2
- 4Insider filing for KYTX
- 3New insider at KYTX
Sravan Kumar Emany, reporting
8-KKyverna Therapeutics, Inc.KYTXLIVE SCHEDULE 13G/AKyverna Therapeutics, Inc.KYTXLIVE Ownership stake disclosure by Northpond Ventures III, LP (amended)
Northpond Ventures III, LP, filed by
SCHEDULE 13G/AKyverna Therapeutics, Inc.KYTXLIVE Ownership stake disclosure by Bain Capital Life Sciences Opportunities III, LP (amended)
Bain Capital Life Sciences Opportunities III, LP, filed by
4Kyverna Therapeutics, Inc.KYTXLIVE 2 insider filings
Mayobanex Pujols, insider filing for KYTX
Show all 2
- 4Insider filing for KYTX
- 3New insider at KYTX
Mayobanex Pujols, reporting
SCHEDULE 13G/AKyverna Therapeutics, Inc.KYTXLIVE Ownership stake disclosure by Westlake BioPartners Fund I, L.P. (amended)
Westlake BioPartners Fund I, L.P., filed by
8-KKyverna Therapeutics, Inc.KYTXLIVE